Use of cilengitide for ameliorating cardiac fibrosis occurring in response to myocardial infarction

Assignee

• Inserm (Institut National De La Santé Et De La Recherche Médicale)
• Université Paris Cité
• Assistance Publique—Hôpitaux De Paris (Aphp)

Inventors

• Jean-Sébastien HULOT (4 patents)

View full patent text on Google Patents →